Information from the Committee
News from the Committee
-
Drug Evaluation Committee
We have posted the presentation slides titled “Reflections on the Impact of the Study Group on the Future of Pharmaceutical Regulations on Post-Marketing Surveys and Other Activities” (July 11, 2026, 28th Assembly and Academic Conference of the Japanese Society for Pharmaceutical Information).
-
Public Affairs Committee
We have published the “JPMA Newsletter, July 2026 Issue No. 230.”
-
Drug Evaluation Committee
We have posted the “Q&A, 5th Edition, Regarding ‘Registration of Clinical Trial Status, etc.’ (Pharmaceutical and Medical Devices Safety and Evaluation Division Notice No. 0831-9, August 31, Reiwa 2).”
-
Drug Evaluation Committee
We have published an article titled “The Revised Next-Generation Medical Infrastructure Act and Post-Marketing Drug Safety Surveillance: Required Actions for Pharmaceutical Companies.”
-
Quality & Technology Committee
We have posted information regarding the “FY2026 GMP Case Study Workshop.”
Committee Activities
Information on the committee's workshops, symposiums, and other events and activities is available.
-
Code Compliance Committee -
Pharmaceutical Industrial Policy Committee -
Distribution Improvement Committee -
Drug Evaluation Committee -
Quality & Technology Committee -
Biopharmaceutical Committee -
Regulatory Affairs Committee -
Intellectual Property Committee -
R&D Committee -
International Affairs Committee -
Public Affairs Committee -
Patient Cooperation Committee -
ICH Project -
APAC Project -
Consumer Consultation Review Committee -
Environmental Issue Committee -
The Office of Pharmaceutical Industry Research